Home › Funds › Commodore Capital LP › COGT

Commodore Capital LP position in COGT

COGENT BIOSCIENCES INC · Health Care

Commodore Capital LP reported holding 3,050,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$118.0M, representing 7.03% of its reported portfolio and ranking #4 among its reported holdings. Commodore Capital LP has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.05M sh
Reported value held$118.03M
Portfolio Weight7.03%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's COGT position evolved

Commodore Capital LP first disclosed a stake in COGT in Q3 2023 at 5,566,026 shares (US$54.3M). The position peaked in Q2 2026 at 3,050,000 shares, worth US$118.0M. Across 12 filings, Commodore Capital LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,050,000 shares valued at US$118.0M — an increase of 161,993 shares quarter over quarter.. Notable position changes include a 74% trim in Q2 2025 (shares rose 100% over the following quarter), a 214% increase in Q3 2025 (shares rose 147% over the following quarter), a 70% trim in Q4 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.57M $54.27M New
Q4 2023 5.57M $32.73M Hold
Q1 2024 6.42M $43.18M Add
Q2 2024 9.74M $82.09M Add
Q3 2024 7.54M $81.43M Reduce
Q4 2024 6.88M $53.68M Reduce
Q1 2025 8.89M $53.27M Add
Q2 2025 2.31M $16.59M Reduce
Q3 2025 7.25M $104.11M Add
Q4 2025 2.20M $78.03M Reduce
Q1 2026 2.89M $111.16M Add
Q2 2026 3.05M $118.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Commodore Capital LP held COGT?

Commodore Capital LP has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Commodore Capital LP's current position in COGT?

As of Q2 2026, Commodore Capital LP holds 3.05M shares of COGT (COGENT BIOSCIENCES INC), valued at $118.03M, representing 7.03% of its reported portfolio and ranking #4.

Has Commodore Capital LP been buying or selling COGT?

In the latest 13F filing (Q2 2026), Commodore Capital LP increased its position in COGT. The position peaked in Q2 2026 at 3.05M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.